OTCMKTS:MYMX Mymetics (MYMX) Stock Price, News & Analysis $0.0003 0.00 (0.00%) As of 07/10/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsBuy This Stock About Mymetics Stock (OTCMKTS:MYMX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Mymetics alerts:Sign Up Key Stats Today's Range$0.0003▼$0.000350-Day Range N/A52-Week Range$0.0003▼$0.0003VolumeN/AAverage VolumeN/AMarket Capitalization$45.00P/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Mymetics (OTCMKTS: MYMX) is a clinical-stage biotechnology company specializing in the development of prophylactic and therapeutic vaccines for infectious diseases. The company’s proprietary virosome‐based delivery platform is designed to present antigens in a lipid bilayer, mimicking the natural presentation of viruses to the immune system. This approach aims to stimulate robust and durable humoral and cellular responses while maintaining a favorable safety profile. The company’s pipeline includes candidates targeting viral pathogens such as influenza, herpes simplex virus (HSV), and human immunodeficiency virus (HIV). Mymetics’ lead programs have advanced through preclinical and early‐stage clinical evaluations, demonstrating proof of concept for its virosome technology. Additional research collaborations have explored applications in pandemic preparedness and emerging infectious diseases. Founded in 1998, Mymetics is headquartered in Belgium with a subsidiary in the United States to support North American development and regulatory activities. The company has focused on leveraging its virosome platform to form strategic partnerships, aiming to accelerate late‐stage clinical trials and commercialization efforts. Its management team comprises professionals with experience in vaccine research, clinical development, and regulatory affairs, guiding the company’s strategic direction in global markets.AI Generated. May Contain Errors. Read More Receive MYMX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mymetics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MYMX Stock News HeadlinesMymetics Corp.May 23, 2026 | marketwatch.comMymetics Stock Price HistoryOctober 22, 2025 | investing.comURGENT Dollar Reset Warning for MondayA 50-year U.S.-Saudi arrangement established under Henry Kissinger - one credited with anchoring the dollar in global trade - is reportedly over. Analyst Garrett Goggin, CFA, CMT believes what follows could be the most significant dollar reset in modern history. Goggin has recorded an emergency briefing outlining what investors should consider doing now - including one asset he believes is positioned to climb sharply, similar to how it performed during the currency turbulence of the 1970s. | Golden Portfolio (Ad)Sp Bmv Ipc Esg Tilted Heavy (MYMX)October 17, 2024 | investing.comPLTXF PlantX Life Inc.March 29, 2024 | seekingalpha.comMymetics Corporation (MYMXD) Stock Historical Prices & Data - Yahoo FinanceFebruary 2, 2024 | finance.yahoo.comMymetics Stock (OTC:MYMX) Dividends: History, Yield and DatesDecember 30, 2023 | benzinga.comOriole Resources project in Cameroon delivers high-grade gold resultsMarch 1, 2023 | lse.co.ukSee More Headlines MYMX Stock Analysis - Frequently Asked Questions How have MYMX shares performed this year? Mymetics' stock was trading at $0.0003 at the beginning of 2026. Since then, MYMX shares have increased by 0.0% and is now trading at $0.0003. How do I buy shares of Mymetics? Shares of MYMX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Mymetics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Mymetics investors own include Dynavax Technologies (DVAX), Fujitsu (FJTSY), Genocea Biosciences (GNCA), Revance Therapeutics (RVNC), Axcelis Technologies (ACLS) and Company Calendar Today7/16/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - BIOMED/GENE Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:MYMX CIK927761 Webwww.mymetics.com Phone(121) 653-4535Fax41-21-653-2473Employees8Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares150,000Free Float144,000Market Cap$45.00 OptionableNot Optionable Beta2.14 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (OTCMKTS:MYMX) was last updated on 7/16/2026 by MarketBeat.com Staff. From Our PartnersThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredURGENT Dollar Reset Warning for MondayA 50-year U.S.-Saudi arrangement established under Henry Kissinger - one credited with anchoring the dollar in...Golden Portfolio | SponsoredWhat will Nvidia do next?Wall Street spends millions on supercomputers and analyst teams to forecast stock prices. Now a new predictive...TradeSmith | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredBlackRock just moved $150 billion into this "new internet"BlackRock CEO Larry Fink's 2026 chairman's letter compared tokenization to the birth of the internet - and the...Awesomely, LLC | Sponsored$30M Could Unlock $500M in MetalA small exploration company is sitting on an estimated $500 million worth of antimony - a critical defense met...i2i Marketing Group, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mymetics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mymetics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
